BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38183576)

  • 1. Physical late effects of treatment among survivors of childhood cancer in low- and middle-income countries: a systematic review.
    Wong KA; Moskalewicz A; Nathan PC; Gupta S; Denburg A
    J Cancer Surviv; 2024 Jan; ():. PubMed ID: 38183576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
    Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
    Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions to improve early detection of childhood cancer in low- and middle-income countries: A systematic review.
    Zabih W; Thota AB; Mbah G; Freccero P; Gupta S; Denburg AE
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28761. PubMed ID: 33037867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic late adverse effects after antineoplastic treatment for childhood cancer.
    Mulder RL; Bresters D; Van den Hof M; Koot BG; Castellino SM; Loke YKK; Post PN; Postma A; Szőnyi LP; Levitt GA; Bardi E; Skinner R; van Dalen EC
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD008205. PubMed ID: 30985922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Outcomes in Survivors of Childhood Cancer: A 30-Year Experience From India.
    Prasad M; Goswami S; Chinnaswamy G; Banavali SD; Kurkure PA
    JCO Glob Oncol; 2022 Nov; 8():e2200044. PubMed ID: 36332172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
    Kooijmans EC; Bökenkamp A; Tjahjadi NS; Tettero JM; van Dulmen-den Broeder E; van der Pal HJ; Veening MA
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008944. PubMed ID: 30855726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional interventions for survivors of childhood cancer.
    Cohen JE; Wakefield CE; Cohn RJ
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD009678. PubMed ID: 27545902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe fatigue after treatment for childhood cancer.
    van Deuren S; Boonstra A; van Dulmen-den Broeder E; Blijlevens N; Knoop H; Loonen J
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012681. PubMed ID: 32124971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional interventions for preventing stunting in children (birth to 59 months) living in urban slums in low- and middle-income countries (LMIC).
    Goudet SM; Bogin BA; Madise NJ; Griffiths PL
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD011695. PubMed ID: 31204795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late mortality among 5-year survivors of childhood cancer: A systematic review and meta-analysis.
    Moskalewicz A; Martinez B; Uleryk EM; Pechlivanoglou P; Gupta S; Nathan PC
    Cancer; 2024 May; 130(10):1844-1857. PubMed ID: 38271115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Modifiable Health Conditions and Social Determinants of Health With Late Mortality in Survivors of Childhood Cancer.
    Ehrhardt MJ; Liu Q; Dixon SB; Caron E; Redd D; Shelton K; Huang IC; Bhakta N; Ness KK; Mulrooney DA; Brinkman TM; Chemaitilly W; Delaney A; Armstrong GT; Srivastava DK; Zaidi A; Robison LL; Yasui Y; Hudson MM
    JAMA Netw Open; 2023 Feb; 6(2):e2255395. PubMed ID: 36763361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of road safety interventions: An evidence and gap map.
    Goel R; Tiwari G; Varghese M; Bhalla K; Agrawal G; Saini G; Jha A; John D; Saran A; White H; Mohan D
    Campbell Syst Rev; 2024 Mar; 20(1):e1367. PubMed ID: 38188231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for improving coverage of childhood immunisation in low- and middle-income countries.
    Oyo-Ita A; Wiysonge CS; Oringanje C; Nwachukwu CE; Oduwole O; Meremikwu MM
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008145. PubMed ID: 27394698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delays and Barriers to Cancer Care in Low- and Middle-Income Countries: A Systematic Review.
    Brand NR; Qu LG; Chao A; Ilbawi AM
    Oncologist; 2019 Dec; 24(12):e1371-e1380. PubMed ID: 31387949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.
    Brown SJ; Carter GJ; Halliwell G; Brown K; Caswell R; Howarth E; Feder G; O'Doherty L
    Cochrane Database Syst Rev; 2022 Oct; 10(10):CD013648. PubMed ID: 36194890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital Health Strategies for Cervical Cancer Control in Low- and Middle-Income Countries: Systematic Review of Current Implementations and Gaps in Research.
    Rossman AH; Reid HW; Pieters MM; Mizelle C; von Isenburg M; Ramanujam N; Huchko MJ; Vasudevan L
    J Med Internet Res; 2021 May; 23(5):e23350. PubMed ID: 34042592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of long-term follow-up care for childhood cancer survivors: A systematic review.
    Signorelli C; Wakefield CE; Fardell JE; Wallace WHB; Robertson EG; McLoone JK; Cohn RJ
    Crit Rev Oncol Hematol; 2017 Jun; 114():131-138. PubMed ID: 28477741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost and cost-effectiveness of childhood cancer treatment in low-income and middle-income countries: a systematic review.
    Fung A; Horton S; Zabih V; Denburg A; Gupta S
    BMJ Glob Health; 2019; 4(5):e001825. PubMed ID: 31749998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Risk of Mild Cognitive Impairment in Low and Middle-Income Countries: A Systematic Review.
    McGrattan AM; Zhu Y; Richardson CD; Mohan D; Soh YC; Sajjad A; van Aller C; Chen S; Paddick SM; Prina M; Siervo M; Robinson LA; Stephan BCM
    J Alzheimers Dis; 2021; 79(2):743-762. PubMed ID: 33361599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.